Inhibiting APOL1 to Treat Kidney Disease

Winfred W. Williams, Julie R. Ingelfinger

The New England journal of medicine（2023）

引用 2|浏览1

暂无评分

摘要

This article describes the science behind a study on the use of inaxaplin in patients with focal segmental glomerulosclerosis who have two risk alleles of the gene APOL1.

查看译文

关键词

kidney disease,apol1

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要